Only logged in customers who have purchased this product may leave a review.
PEG-MGF
Research Grade Peptide
- Research Grade
- 99% Purity
- Third-Party Verified
Reference Strength: 2mg
PEG-MGF
PEG MGF is a pegylated variant of mechano-growth factor (MGF), an IGF-1 splice variant investigated for muscle regeneration, tissue repair and recovery.
Included with your purchase
Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About PEG-MGF
PEGylation extends the half-life of MGF, allowing longer systemic exposure than native MGF. Experimental studies have explored its role in satellite cell activation, muscle repair and connective tissue regeneration.
How It Works in Research
MGF is an IGF-1 splice variant expressed after mechanical loading or injury. Preclinical research suggests it activates satellite cells and supports local protein synthesis. PEGylation prolongs circulating half-life, enabling once-daily subcutaneous administration in research models.
Research Applications
• Muscle regeneration • Recovery • Satellite cells • Connective tissue • Bone repair • Cartilage biology
Researchers study PEG MGF because it may help support muscle repair and regeneration following mechanical stress or injury.
Product Specifications
- Product Name: PEG MGF
- Reference Strength: 2 mg
- Appearance: White to off-white lyophilised powder
- Purity Standard: ≥98% (HPLC)
Research Information
- Category: Pegylated growth factor peptide
- Reconstitution: 3.0 mL bacteriostatic water
- Final Concentration: 0.667 mg/mL
- Storage: 2–8°C after reconstitution
Mechanism of Action
MGF is an IGF-1 splice variant expressed after mechanical loading or injury. Preclinical research suggests it activates satellite cells and supports local protein synthesis. PEGylation prolongs circulating half-life, enabling once-daily subcutaneous administration in research models.
Potential Benefits in Research
May support muscle regeneration.
- May promote satellite cell activation.
- May enhance recovery after muscle injury.
- Preclinical evidence suggests support for bone and cartilage repair.
- May assist local tissue regeneration.
Safety Profile
May support muscle regeneration.
- May promote satellite cell activation.
- May enhance recovery after muscle injury.
- Preclinical evidence suggests support for bone and cartilage repair.
- May assist local tissue regeneration.
Research Applications
No completed human clinical trials.
Long-term human safety has not been established.
Mild injection-site irritation may occur.
Evidence is primarily from laboratory and animal studies.
No human clinical dosing has been established.
REFERENCE RECONSTITUTION INFORMATION
Goal: Support muscle recovery and regeneration through MGF-mediated satellite cell activation. Schedule: Daily subcutaneous injections for 8 weeks (optional extension to 12–16 weeks). Dose Range: 200–500 mcg daily. Reconstitution: Add 3.0 mL bacteriostatic water to one 2 mg vial (~0.667 mg/mL).
Always follow sterile preparation techniques when handling research peptides.
Goal: Support muscle recovery and regeneration through MGF-mediated satellite cell activation.
Schedule: Daily subcutaneous injections for 8 weeks (optional extension to 12–16 weeks).
Dose Range: 200–500 mcg daily.
Reconstitution: Add 3.0 mL bacteriostatic water to one 2 mg vial (~0.667 mg/mL).
General Preparation
• Use a new sterile syringe for each injection. • Rotate injection sites. • Inject slowly and consistently. • Document dosing and injection sites. • No human clinical dosing has been established.
- Slowly add 3.0 mL bacteriostatic water down the vial wall. Allow the powder to dissolve naturally and gently swirl until clear. Do not shake vigorously.
PEG-MGF (2MG)- RECONSTITUTION TABLES
Reference Handling Information
Reference information for laboratory handling of PEG-MGF.
- Schedule: Daily subcutaneous injections for 8 weeks (optional extension to 12–16 weeks).
- Dose Range: 200–500 mcg daily.
Reference Parameters (Dosing Protocol)
| Week | Daily Dose | U-100 Units | Volume |
|---|---|---|---|
| Weeks 1–2 | 200 mcg | 30 units | 0.30 mL |
| Weeks 3–4 | 300 mcg | 45 units | 0.45 mL |
| Weeks 5–6 | 400 mcg | 60 units | 0.60 mL |
| Weeks 7–8 | 500 mcg | 75 units | 0.75 mL |
For laboratory research only.
Experimental Study Period
STUDY PERIOD
8 weeks (optional extension to 12–16 weeks)
RESEARCH CONTEXT
Support muscle recovery and regeneration through MGF-mediated satellite cell activation.
Daily subcutaneous injections for 8 weeks (optional extension to 12–16 weeks).
View Certificate of Analysis
View Certificate of Analysis Each batch of PEG-MGF is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
99%
Verified Purity
3rd Party
Lab Tested
Certified
Quality Assured
Related products
-
Skin, Hormonal & Vitality Research
GHK-Cu
Price range: R599,00 through R799,00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
PURE PERFORMANCE LABS
Recommended Research Products
Explore related compounds commonly viewed alongside this product.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.
Reviews
There are no reviews yet.